Crossmark

Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacement

Crossref DOI link: https://doi.org/10.1186/s12865-020-00368-7

Published Online: 2020-06-29

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Weide, Rudolf https://orcid.org/0000-0002-7594-9398
Schnell, Roland

Schardt, Christof

Koenigsmann, Michael

Otremba, Burkhard

Zahn, Mark-Oliver

Wierecky, Jan

Braun, Ute

Hensel, Manfred

Klausmann, Martine

Fleckenstein, Doris

Ehscheidt, Peter

Feiten, Stefan
Funding

Funding for this research was provided by:

Biotest AG
License Information

Text and Data Mining valid from 2020-06-29

Version of Record valid from 2020-06-29
More Information

Article History

Received: 17 March 2020

Accepted: 17 June 2020

First Online: 29 June 2020

Ethics approval and consent to participate

: This study was approved by the ethics committee of Rhineland-Palatinate, Germany.Written informed consent was obtained from all participants. All procedures performed in this study were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Not applicable.

: All authors declare no competing interests.

Document is current

Any future updates will be listed below